Mengxuan Zuo

机构：Sun Yat-sen University, Chinese PLA General Hospital, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China

发表论文 6 篇 · 总被引 30 次 · h-index 3

代表论文

• Hepatic arterial infusion chemotherapy plus camrelizumab and apatinib for advanced hepatocellular carcinoma (2024 · Hepatology International · 被引 15)
• Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study (2024 · British Journal of Cancer · 被引 7)
• An automated machine-learning model for prognostic risk stratification of intermediate-stage hepatocellular carcinoma after transarterial chemoembolization (2025 · International Journal of Surgery · 被引 5)
• Identification and validation of an explainable machine learning model for hepatocellular carcinoma at high risk: a retrospective multicenter cohort study (2025 · International Journal of Surgery · 被引 2)
• Radiological characteristics for guiding intra-arterial therapy in intermediate-stage hepatocellular carcinoma (2025 · BMC Medicine · 被引 1)
• Proliferative Subtype–Based Deep Learning Model for Identifying the Survival Benefit of Patients with Hepatocellular Carcinoma Receiving Intra-Arterial Therapies (2025 · SSRN Electronic Journal)